Possible role of cyclic-3', 5'-adenosine monophosphate in the release of catecholamines from the adrenal medulla
Izumi, F.; Oka, M.; Kashimoto, T.
Medical Journal of Osaka University 21(4): 241-249
1971
ISSN/ISBN: 0030-6169 PMID: 4338178 Document Number: 41073
Document emailed within 1 workday
Related Documents
Cubeddu, L.; Barnes, E.; Weiner, N. 1975: Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate Journal of Pharmacology and Experimental Therapeutics 193(1): 105-127Yamasaki, Y.; Fujiwara, M.; Toda, N. 1974: Effects of intracellularly applied cyclic 3',5'-adenosine monophosphate and dibutyryl cyclic 3',5'-adenosine monophosphate on the electrical activity of sinoatrial nodal cells of the rabbit Journal of Pharmacology and Experimental Therapeutics 190(1): 15-20
Tran, M.A.; Damase-Michel, C.; Tavernier, G.; Giraud, P.; Montastruc, J.L.; Montastruc, P. 1993: Co-release of neuropeptides and catecholamines by adrenal medulla Archives des Maladies du Coeur et des Vaisseaux 86(8): 1253-1256
Pinto, J.E.; Politi, P.M.; Fernandez, B. 1987: Effects of doxorubicin on the release of catecholamines from the bovine adrenal medulla Archives Internationales de Pharmacodynamie et de Therapie 289(1): 140-148
Nedvídková, J.; Felt, V. 1984: Plasma levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in patients with thyropathies Casopis Lekaru Ceskych 123(27): 835-837
Polson, J.B.; Krzanowski, J.J.; Szentivanyi, A. 1974: Histamine induced changes in pulmonary guanosine-3',5'-cyclic monophosphate (cGMP) and adenosine-3',5'-cyclic monophosphate (cAMP) levels in mice following sensitization by Bordetella pertussis and/or propranolol Research Communications in Chemical Pathology and Pharmacology 9(2): 243-251
Nakaki, T.; Nakadate, T.; Ishii, K.; Kato, R. 1981: Postsynaptic alpha-2 adrenergic receptors in isolated rat islets of Langerhans: inhibition of insulin release and cyclic 3':5'-adenosine monophosphate accumulation Journal of Pharmacology and Experimental Therapeutics 216(3): 607-612
Vollenberger, A.; Kraus, E.G.; Geier, G.; Gents, S. 1972: The behavior and role of cyclic adenosine monophosphate in the myocardium during acute ischemia Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 16(3): 13-16
Zhikharev, S.S. 1977: Role of disorders of cyclic adenosine-3',5'--monophosphate (cAMP) in the pathogenesis of bronchial asthma Terapevticheskii Arkhiv 49(3): 131-135
Osipov, E.V.; Burobin, V.A.; Karelin, A.A. 1976: Role of cyclic adenosine-3',5'-monophosphate in the regulation of histidase in the skin in the process of ontogeny Voprosy Meditsinskoi Khimii 22(2): 203-209
Mikulíková, D.; Trnavský, K. 1980: Colchicine derivatives and their effect on lysosomal enzyme release from polymorphonuclear leukocytes and on intracellular levels of 3',5'cyclic adenosine monophosphate following urate crystal phagocytosis Casopis Lekaru Ceskych 119(51): 1398-1401
Yang, Y.; Wang, W.-S.; Qiu, Y.; Sun, L.-H.; Yang, H. 2013: Role of cyclic adenosine monophosphate(cAMP) in the regulation of intestinal epithelial barrier function under hypoxia Zhonghua Wei Chang Wai Ke Za Zhi 16(5): 479-483
Szczechowski, L.; Lenart-Grabowska, M.; Marczewska, E. 1989: The role of adenosine cyclic monophosphate (c-AMP) in the pathogenesis of epilepsy and the mechanism of the action of anti-epileptic drugs Wiadomosci Lekarskie 42(13-15): 881-883
Nikulin, A.A. 1978: Effect of cyclic adenosine monophosphate and guanosine monophosphate on the aggregation and nucleotide metabolism of the blood platelets Farmakologiia i Toksikologiia 41(2): 177-182
Pepe, S.; Tortora, G.; Noguchi, P.D.; Marti, G.E.; Washington, G.C.; Cho-Chung, Y.S. 1991: Effects of 8-chloroadenosine 3',5'-monophosphate and N6-benzyl-cyclic adenosine 5'-monophosphate on cell cycle kinetics of HL-60 leukemia cells Cancer Research 51(23 Part 1): 6263-6267
Fuller, R.W.; Snoddy, H.D.; Bromer, W.W. 1972: Increase of hepatic L-phenylalanine: pyruvate aminotransferase by glucagon in rats. Possible role of adenosine cyclic 3',5'-monophosphate as a mediator Molecular Pharmacology 8(3): 345-352
Georgieva, Z.; Uzunov, P. 1988: The diterpene forskolin--a valuable agent for demonstrating the role of the cyclic 3',5'-adenosine monophosphate system in physiological processes Eksperimentalna Meditsina i Morfologiia 27(1): 56-61
Gamelli, R.L.; He, L.K.; Liu, H.; Ricken, J.D. 1998: Burn wound infection-induced myeloid suppression: the role of prostaglandin E2, elevated adenylate cyclase, and cyclic adenosine monophosphate Journal of Trauma 44(3): 469-474
Poisner, A.M.; Bernstein, J. 1971: A possible role of microtubules in catecholamine release from the adrenal medulla: effect of colchicine, vinca alkaloids and deuterium oxide Journal of Pharmacology and Experimental Therapeutics 177(1): 102-108
Bershteĭn, L.M.; Dil'man, V.M. 1974: Cyclic adenosine monophosphate and prostaglandins in oncology Voprosy Onkologii 20(3): 105-120